Ryan Murr > Gibson, Dunn & Crutcher LLP > San Francisco, United States > Lawyer Profile

Gibson, Dunn & Crutcher LLP
555 Mission Street, Suite 3000
San Francisco, CA 94105-0921
CALIFORNIA
United States

Work Department

Life Sciences, Corporate, Capital Markets

Position

Co-chair, global life sciences practice, Ryan focuses on representing operating companies and investors in the biotechnology, pharmaceutical, diagnostics and medical device industries in connection with securities offerings, corporate governance matters and business combination transactions. He serves as principal outside counsel for publicly-traded companies and venture-backed companies, advising management teams and boards of directors on general corporate matters, securities offerings, SEC reporting, corporate governance, licensing transactions and mergers & acquisitions. He also advises investment funds (private equity funds, hedge funds, venture funds and royalty buyout funds) in connection with investments in life sciences companies and assets.

Career

For more information, please visit https://www.gibsondunn.com/lawyer/murr-ryan-a/.

Lawyer Rankings

United States > Healthcare > Life sciences

The life sciences team at Gibson, Dunn & Crutcher LLP advises a diverse client roster of life sciences and investment companies, including Gilead Sciences, the Dana-Farber Cancer Institute, and Amyris. Jane Love leads the team alongside Ryan Murr, working from New York and San Francisco, respectively. Love routinely acts in patent litigations concerning biologics, RNA therapies, and therapeutic nucleic acids, while Murr advises investors targeting the medical device and diagnostics, biotech, and pharmaceutical industries on securities offerings and licensing transactions. Working out of the San Francisco office, Brandon Berns assists clients with corporate transactional matters, while of counsel Todd Trattner works with research institutes, diagnostics companies, and biotech companies – both public and private – on IP transactions. Charlotte Jacobsen joined the New York practice from Ropes & Gray LLP in April 2022, contributing her experience in handling chemical and biotech patent and licensing disputes, often appearing before the PTAB, AAA, and ICC.